Skip to main content
Skip to footer
Sign in to read the full text
The document summary and details above are public. The full text is available to signed-in accounts.
States / Minnesota / Bill text
Bill text
Introduction
HF 4852 — Formulary Committee members with a potential conflict of interest permitted to participate in committee communications and discussions, commissioner of human services required to develop a public comment process for recommendations, and committee required to seek expertise from the Minnesota Rare Disease Advisory Council.
HF 4852 (Introduction)
Introduction text of HF 4852.